动脉瘤性蛛网膜下腔出血后全身性炎症的早期标志物与疼痛负担无关:一项多中心观察研究

IF 3.6 3区 医学 Q2 CLINICAL NEUROLOGY
Adam Kardon, Haoyu Ren, Emily Gerard, Daniela Pomar-Forero, Ralisa Pop, Bakhtawar Ahmad, Prajwal Ciryam, Gunjan Parikh, Neeraj Badjatia, Carolina B Maciel, Katharina M Busl, Chixiang Chen, Nicholas A Morris
{"title":"动脉瘤性蛛网膜下腔出血后全身性炎症的早期标志物与疼痛负担无关:一项多中心观察研究","authors":"Adam Kardon, Haoyu Ren, Emily Gerard, Daniela Pomar-Forero, Ralisa Pop, Bakhtawar Ahmad, Prajwal Ciryam, Gunjan Parikh, Neeraj Badjatia, Carolina B Maciel, Katharina M Busl, Chixiang Chen, Nicholas A Morris","doi":"10.1007/s12028-025-02396-w","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Headache is nearly ubiquitous in the immediate aftermath of nontraumatic, aneurysmal pattern subarachnoid hemorrhage (SAH); however, pain experiences vary significantly throughout the intensive care unit (ICU) course across patients and may challenge the establishment of effective analgesic treatment. Acute abortive management often relies on opioids. The pathophysiologic factors driving persistent pain after SAH are likely related to the inflammatory response to blood-brain barrier breakdown and heme degradation. Scarce data on predictors for a course of refractory headache preclude the ability to risk stratify and identify patients who could benefit from targeted, opioid-sparing pain management strategies. We aimed to identify clinical and laboratory predictors of a persistently high pain burden during the ICU course.</p><p><strong>Methods: </strong>We performed a retrospective, multicenter observational study in patients with SAH. Pain scores were abstracted from the electronic health record. Study participants were divided into quartiles based on the average burden of daily pain, and predictors of pain burden were identified by univariate analysis and ordinal logistic regression. We performed a sensitivity analysis restricted to patients able to verbally report pain scores in the ICU.</p><p><strong>Results: </strong>Of the 523 patients in the final analysis, the mean age was 55 years, 352 (67%) were female, the median Hunt-Hess score was 3 (interquartile range 2-3), and 465 (89%) had a modified Fisher score of 3 or 4. Older age was associated with lower ICU pain burden (odds ratio 1.01, 95% confidence interval 1.01-1.03). Chronic opioid use (odds ratio 0.59, 95% confidence interval 0.38-0.90) was associated with a higher ICU pain burden. Conversely, blood inflammatory biomarkers were not associated with high ICU pain burden in the univariate or multivariate analysis. The results were similar among the subgroup of patients able to verbally report pain scores throughout admission.</p><p><strong>Conclusions: </strong>In this multicenter study, young age and chronic opioid use are associated with higher ICU pain burden, whereas inflammatory blood biomarkers lack an association. Further study is required to elucidate the biological pathways and psychosocial determinants of protracted pain after aneurysmal SAH.</p>","PeriodicalId":19118,"journal":{"name":"Neurocritical Care","volume":" ","pages":""},"PeriodicalIF":3.6000,"publicationDate":"2025-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Early Markers of Systemic Inflammation are not Related to Pain Burden After Aneurysmal Subarachnoid Hemorrhage: A Multicenter Observational Study.\",\"authors\":\"Adam Kardon, Haoyu Ren, Emily Gerard, Daniela Pomar-Forero, Ralisa Pop, Bakhtawar Ahmad, Prajwal Ciryam, Gunjan Parikh, Neeraj Badjatia, Carolina B Maciel, Katharina M Busl, Chixiang Chen, Nicholas A Morris\",\"doi\":\"10.1007/s12028-025-02396-w\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Headache is nearly ubiquitous in the immediate aftermath of nontraumatic, aneurysmal pattern subarachnoid hemorrhage (SAH); however, pain experiences vary significantly throughout the intensive care unit (ICU) course across patients and may challenge the establishment of effective analgesic treatment. Acute abortive management often relies on opioids. The pathophysiologic factors driving persistent pain after SAH are likely related to the inflammatory response to blood-brain barrier breakdown and heme degradation. Scarce data on predictors for a course of refractory headache preclude the ability to risk stratify and identify patients who could benefit from targeted, opioid-sparing pain management strategies. We aimed to identify clinical and laboratory predictors of a persistently high pain burden during the ICU course.</p><p><strong>Methods: </strong>We performed a retrospective, multicenter observational study in patients with SAH. Pain scores were abstracted from the electronic health record. Study participants were divided into quartiles based on the average burden of daily pain, and predictors of pain burden were identified by univariate analysis and ordinal logistic regression. We performed a sensitivity analysis restricted to patients able to verbally report pain scores in the ICU.</p><p><strong>Results: </strong>Of the 523 patients in the final analysis, the mean age was 55 years, 352 (67%) were female, the median Hunt-Hess score was 3 (interquartile range 2-3), and 465 (89%) had a modified Fisher score of 3 or 4. Older age was associated with lower ICU pain burden (odds ratio 1.01, 95% confidence interval 1.01-1.03). Chronic opioid use (odds ratio 0.59, 95% confidence interval 0.38-0.90) was associated with a higher ICU pain burden. Conversely, blood inflammatory biomarkers were not associated with high ICU pain burden in the univariate or multivariate analysis. The results were similar among the subgroup of patients able to verbally report pain scores throughout admission.</p><p><strong>Conclusions: </strong>In this multicenter study, young age and chronic opioid use are associated with higher ICU pain burden, whereas inflammatory blood biomarkers lack an association. Further study is required to elucidate the biological pathways and psychosocial determinants of protracted pain after aneurysmal SAH.</p>\",\"PeriodicalId\":19118,\"journal\":{\"name\":\"Neurocritical Care\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.6000,\"publicationDate\":\"2025-10-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neurocritical Care\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s12028-025-02396-w\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurocritical Care","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12028-025-02396-w","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:非创伤性动脉瘤样蛛网膜下腔出血(SAH)后立即出现头痛几乎是普遍存在的;然而,在重症监护病房(ICU)的整个过程中,患者的疼痛经历差异很大,这可能对有效镇痛治疗的建立构成挑战。急性流产的治疗通常依赖于阿片类药物。导致SAH后持续疼痛的病理生理因素可能与血脑屏障破坏和血红素降解的炎症反应有关。难治性头痛的预测因素数据匮乏,因此无法对患者进行风险分层,并确定哪些患者可以从有针对性的、不使用阿片类药物的疼痛管理策略中获益。我们的目的是确定在ICU过程中持续高疼痛负担的临床和实验室预测因素。方法:我们对SAH患者进行了一项回顾性、多中心观察性研究。疼痛评分从电子健康记录中提取。研究对象根据每日疼痛的平均负担分为四分位数,并通过单变量分析和有序逻辑回归确定疼痛负担的预测因子。我们进行了一项敏感性分析,仅限于能够口头报告ICU疼痛评分的患者。结果:在最终分析的523例患者中,平均年龄为55岁,352例(67%)为女性,Hunt-Hess评分中位数为3(四分位数范围为2-3),465例(89%)的Fisher评分为3或4。年龄越大,ICU疼痛负担越轻(优势比1.01,95%可信区间1.01-1.03)。慢性阿片类药物使用(优势比0.59,95%可信区间0.38-0.90)与较高的ICU疼痛负担相关。相反,在单因素或多因素分析中,血液炎症生物标志物与高ICU疼痛负担无关。在住院期间能够口头报告疼痛评分的患者亚组中,结果相似。结论:在这项多中心研究中,年轻和慢性阿片类药物使用与较高的ICU疼痛负担相关,而炎症性血液生物标志物缺乏相关性。需要进一步的研究来阐明动脉瘤性SAH后持续疼痛的生物学途径和社会心理决定因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Early Markers of Systemic Inflammation are not Related to Pain Burden After Aneurysmal Subarachnoid Hemorrhage: A Multicenter Observational Study.

Background: Headache is nearly ubiquitous in the immediate aftermath of nontraumatic, aneurysmal pattern subarachnoid hemorrhage (SAH); however, pain experiences vary significantly throughout the intensive care unit (ICU) course across patients and may challenge the establishment of effective analgesic treatment. Acute abortive management often relies on opioids. The pathophysiologic factors driving persistent pain after SAH are likely related to the inflammatory response to blood-brain barrier breakdown and heme degradation. Scarce data on predictors for a course of refractory headache preclude the ability to risk stratify and identify patients who could benefit from targeted, opioid-sparing pain management strategies. We aimed to identify clinical and laboratory predictors of a persistently high pain burden during the ICU course.

Methods: We performed a retrospective, multicenter observational study in patients with SAH. Pain scores were abstracted from the electronic health record. Study participants were divided into quartiles based on the average burden of daily pain, and predictors of pain burden were identified by univariate analysis and ordinal logistic regression. We performed a sensitivity analysis restricted to patients able to verbally report pain scores in the ICU.

Results: Of the 523 patients in the final analysis, the mean age was 55 years, 352 (67%) were female, the median Hunt-Hess score was 3 (interquartile range 2-3), and 465 (89%) had a modified Fisher score of 3 or 4. Older age was associated with lower ICU pain burden (odds ratio 1.01, 95% confidence interval 1.01-1.03). Chronic opioid use (odds ratio 0.59, 95% confidence interval 0.38-0.90) was associated with a higher ICU pain burden. Conversely, blood inflammatory biomarkers were not associated with high ICU pain burden in the univariate or multivariate analysis. The results were similar among the subgroup of patients able to verbally report pain scores throughout admission.

Conclusions: In this multicenter study, young age and chronic opioid use are associated with higher ICU pain burden, whereas inflammatory blood biomarkers lack an association. Further study is required to elucidate the biological pathways and psychosocial determinants of protracted pain after aneurysmal SAH.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Neurocritical Care
Neurocritical Care 医学-临床神经学
CiteScore
7.40
自引率
8.60%
发文量
221
审稿时长
4-8 weeks
期刊介绍: Neurocritical Care is a peer reviewed scientific publication whose major goal is to disseminate new knowledge on all aspects of acute neurological care. It is directed towards neurosurgeons, neuro-intensivists, neurologists, anesthesiologists, emergency physicians, and critical care nurses treating patients with urgent neurologic disorders. These are conditions that may potentially evolve rapidly and could need immediate medical or surgical intervention. Neurocritical Care provides a comprehensive overview of current developments in intensive care neurology, neurosurgery and neuroanesthesia and includes information about new therapeutic avenues and technological innovations. Neurocritical Care is the official journal of the Neurocritical Care Society.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信